Can a person with a positive genetic test for Huntington's disease (HD) not develop symptoms of the disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Huntington's Disease Genetic Testing and Disease Development

Yes, a person with a positive genetic test for Huntington's disease may not develop symptoms if their CAG repeat count falls within the reduced penetrance range of 36-39 repeats. 1

Understanding CAG Repeat Ranges and Disease Manifestation

Huntington's disease (HD) is caused by an expansion of CAG trinucleotide repeats in exon 1 of the HTT gene. The number of repeats determines whether and when an individual will develop symptoms:

  • Normal alleles (≤26 CAG repeats): Never associated with HD phenotype 1, 2
  • Mutable normal alleles (27-35 CAG repeats): Not associated with HD symptoms but may expand in future generations, particularly through paternal transmission 1
  • Reduced penetrance alleles (36-39 CAG repeats): Associated with HD in some individuals but not others - this is the key range where a positive test may not lead to disease development 1, 2
  • Full penetrance alleles (≥40 CAG repeats): Disease is fully penetrant, meaning symptoms will eventually develop if the person lives a normal lifespan 1, 2

Reduced Penetrance Range (36-39 CAG Repeats)

The reduced penetrance range is particularly important in answering this question:

  • Individuals with 36-39 CAG repeats have been reported in both clinically affected and clinically unaffected individuals 1
  • In rare cases, elderly individuals with alleles in this range have remained asymptomatic throughout their lives 1
  • For these individuals, it's impossible to determine with certainty whether they will develop HD symptoms 1

Full Penetrance Range (≥40 CAG Repeats)

For individuals with ≥40 CAG repeats:

  • The disease is considered fully penetrant 1, 2
  • Symptoms will eventually develop if the person lives a normal lifespan
  • However, the guidelines do note that there has been at least one documented case of an individual with ≥40 CAG repeats who died disease-free after living to or past normal life expectancy 1

Clinical Implications

  • Genetic testing for HD has several applications: diagnostic confirmation, predictive testing, and prenatal testing 2
  • Tests that effectively detect and measure the CAG repeat region are >99% sensitive 1
  • Positive results with ≥40 CAG repeats are 100% specific for HD diagnosis 1, 2
  • For alleles in the 36-39 range, it's not possible to determine the specificity of the test 1

Important Considerations for Genetic Testing

  • Predictive testing should not be offered to individuals until they are at least 18 years old 1
  • A formal multidisciplinary predictive testing protocol should be offered to individuals desiring determination of their carrier status 1, 2
  • The age of onset correlates inversely with CAG repeat length - longer repeats typically lead to earlier onset 2

Pitfalls and Caveats

  • A positive genetic test with 36-39 CAG repeats cannot definitively predict whether an individual will develop HD
  • Even with ≥40 CAG repeats, the age of symptom onset can vary considerably
  • Genetic counseling is essential before and after testing to help individuals understand the implications of their results, especially for those with repeat counts in the reduced penetrance range
  • The absence of symptoms does not mean an individual with a positive test (≥40 repeats) will never develop the disease - symptoms may develop later in life

In summary, while Huntington's disease is generally considered fully penetrant at ≥40 CAG repeats, individuals with 36-39 repeats may never develop the disease despite having a positive genetic test.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Huntington's Disease Genetics and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.